Novartis sells parts of Sandoz U.S. to India's Aurobindo for $900 million

Filed under: News |

Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India’s Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.



List your business in the premium web directory for free This website is listed under Human Resources Directory